Elbow tuberculosis is a rare disease which accounts for 1-3% of all cases of osteoarticular tuberculosis. The diagnosis of tuberculous arthritis is very difficult in most clinical situations because of the insidious onset, indolent process, and mild and non-specific local or systemic symptoms. Thus, the confirmatory diagnosis and effective treatment for tuberculous arthritis are delayed until the disease progresses to an advanced stage in many clinical settings. Herein we report a case of septic arthritis of the elbow due to Mycobacterium tuberculosis as a result of misdiagnosis and delayed treatments.
Background: Rocuronium bromide is a new steroidal nondepolarizing neuromusular blocking drug characterized by a rapid onset and intermediate duration of action. I.V. rocuronium produces intense discomfort at the site of injection, so many trials have been conducted on prevention of pain induced by I.V. rocuronium. This study evaluate venous retension induced forearm was squeezed with a tourniquet, affect lidocaine efficacy.Methods: Test was performed alert patients and unconscious patients. One group received lidocaine (0.5 mg/kg) and the other forearm was squeezed with tourniquet keeping the lidocaine (0.5 mg/kg) within the vein. After 30, 60 seconds rocuronium (0.6 mg/kg) was injected. propofol (2 mg/kg) induce patients unconsiousness.Results: There was statistical difference in reduction pain and withdrawal among groups. Squeezing group showed less pain and withdrawal than no squeezing group.Conclusions: Venous retension induced forearm was squeezed with a tourniquet, lidocaine reduce pain and withdrawal movement more effectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.